Option chain shows key data for Qualigen Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Qualigen Therapeutics.

Qualigen Therapeutics (NASDAQ:QLGN) Stock, Option Chain

Qualigen Therapeutics

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

Tesla's Gross Margin Shows Worst Is Behind, Creating A 'Goldilocks' Scenario For Bulls, Says Dan Ives — Elon Musk-Led EV Giant Surges Over 12% In After-Hours Trading

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CARR

CCTG

CNSP

DBVT

GORO

ICLR

LRHC

MNDR

ORKT

Qualigen Therapeutics, Inc. - Common Stock

QLGN

SDRL

SVRE

TSLA

VEEE

ZPTA

Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Gold-image

Earnings

Equities

Eurozone

Commodities

APLD

CHPT

EAST

HOTH

NSSC

SAIC

Gold Moves Higher; Science Applications International Posts Upbeat Earnings

Crude-oil-4-logo

SGLY

SIFY

Dow Tumbles 1%; US Crude Oil Stocks Fall

Qualigen Therapeutics Inc

Stock Split

APLM

Apollomics Announces 1-For-100 Reverse Share Split Effective November 25, 2024, With Trading On A Split-Adjusted Basis Under Existing Symbol APLM

AIRE

reAlpha Acquires USRealty

Mizuho analyst Salim Syed maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Outperform and lowers the price target from $251 to $207.

Price Target

Analyst Ratings

BIIB

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $207

RLYB

Rallybio Initiates Phase 2 Trial Of RLYB212 To Address HPA-1a Alloimmunization And FNAIT In Pregnant Women, With Screening Underway Across European Sites For Target Enrollment Of Eight Participants

ExxonMobil Announces $200M Investment To Expand Advanced Recycling Operations In Texas, Targeting 1 Billion Pounds Annual Capacity By 2027 With Additional Units Planned Globally

Moody's Acquires Numerated Growth Technologies, Terms Not Disclosed

Goldman Sachs analyst Toshiya Hari maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $150 to $165.

NVDA

Goldman Sachs Maintains Buy on NVIDIA, Raises Price Target to $165

ASST

NFLX

Asset Entities Partners With Netflix Star Jas Leverette To Launch Subscription-Based Digital Dog Training Community On Discord, Featuring Training From Cali K9 Team

Contracts

SPAI

Safe Pro Enters MOU With A US Prime Contractor For Purchase Order For Real-World Landmine And Unexploded Ordnance Imagery

WIIM

Genius Group shares are trading higher after the company announced it increased its Bitcoin purchases for its Bitcoin Treasury by an additional $4 million for a total of 153 Bitcoins worth $14 million.

Wells Fargo analyst Mohit Bansal initiates coverage on Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) with a Overweight rating and announces Price Target of $70.

Initiation

VERA

Wells Fargo Initiates Coverage On Vera Therapeutics with Overweight Rating, Announces Price Target of $70

Deutsche Bank analyst Michael Linenberg maintains Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) with a Buy and raises the price target from $60 to $80.

Deutsche Bank Maintains Buy on Delta Air Lines, Raises Price Target to $80

ATKR

Atkore shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results and issued FY25 adjusted EPS guidance below estimates.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Genius Group Expands Bitcoin Treasury By 40%, Bringing Total To 153 Bitcoin Worth $14M As Part Of Its $120M Bitcoin-First Strategy

On Thursday, Baidu, Inc&nbsp;(NASDAQ:&nbsp;BIDU) reported&nbsp;fiscal third-quarter&nbsp;revenue of $4.78 billion, down 3% year-on-year, topping the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42105682/baidu-announces-third-quarter-2024-results" rel="noreferrer noopener">analyst&nbsp;consensus estimate of $4.69 billion</a>.&nbsp;
Baidu&#8217;s adjusted earnings per ADS&nbsp;of $2.37 beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $2.35</a>. The stock price slid after the print.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/24/11/42088437/qualcomm-targets-900-billion-market-by-2030-big-bets-on-iot-and-automotive" rel="noreferrer noopener">Qualcomm Targets $900 Billion Market by 2030: Big Bets on IoT and Automotive</a>
Segments:&nbsp;Baidu&#8217;s Core revenue remained flat year over year at $3.78 billion; Online marketing revenue declined by 4% year over year to $2.68 billion. Non-online marketing revenue&nbsp;grew 12% year over year to&nbsp;$1.10 billion, driven by the AI Cloud business.&nbsp;
Revenue from&nbsp;IQIYI, Inc&nbsp;(NASDAQ:&nbsp;IQ) decreased 10% year over year to $1.03 billion, beating the analyst consensus estimate of $1.02 billion.&nbsp;
Baidu&#8217;s SG&amp;A expenses were $836 million, up by 2% year over year, primarily due to an increase in channel spending and promotional marketing expenses. R&amp;D expenses declined 12% year over year to $765 million, primarily due to a decrease in personnel-related expenses.&nbsp;&nbsp;
Baidu&#8217;s adjusted EBITDA margin declined 200 bps to 26%, and its Core adjusted EBITDA margin&nbsp;decreased by 100 bps to 31%. As of September 30, 2024, Baidu had $20.59 billion in cash and equivalents and generated $376 million in free cash flow.&nbsp;
Co-founder and CEO Robin Li said Baidu Core&#8217;s flat third-quarter revenue reflected ongoing weakness in the online marketing business, balanced by growth in the AI Cloud segment.
Strong AI capabilities gained broader market recognition, with ERNIE seeing increased adoption. Apollo Go maintained its leadership in the global autonomous ride-hailing market, achieving a milestone as the sixth-generation autonomous vehicle began operating on public roads in multiple Chinese cities.
Despite near-term challenges, Baidu remains committed to its AI-focused strategy, aiming to scale AI and drive innovation for consumers, enterprises, and society.
Interim CFO Junjie He said Baidu&#8217;s strict cost control measures supported stable operating margins for Baidu Core in the third quarter, with further cost optimizations across business units.
AI Cloud sustained healthy growth, and Apollo Go&#8217;s operational progress reinforced confidence in the fully autonomous ride-hailing business model.
Baidu&nbsp;stock plunged 25% year-to-date as it grappled with a weak economy, U..S. semiconductor sanctions on China.
Price Action: At the last check on Thursday, BIDU stock traded lower by 2.25% at $84.80 in the premarket session.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42092265/stmicroelectronics-targets-18-billion-revenue-eyes-22-24-margins-by-2028" target="_blank" rel="noreferrer noopener">STMicroelectronics Targets $20 Billion Revenue By 2030, Unveils 2027 Goals</a></li>
</ul>
Image via Shutterstock

Emerging Markets

Tech

BIDU

Baidu's Q3 Earnings: Revenue Slides, Weak Online Ads Market Impact Margins

ENPH

Enphase Energy Launches IQ PowerPack 1500, A 1,500Wh Portable Energy System Now Available For Pre-Order In The US And Canada, Designed To Power Small Appliances Anywhere

Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 162.16 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $3.03 million which missed the analyst consensus estimate of $3.53 million by 14.21 percent. This is a 22.27 percent increase over sales of $2.48 million the same period last year.

NNOX

Nano X Imaging Q3 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate, Sales $3.03M Miss $3.53M Estimate

SMCI

Super Micro Computer shares are trading higher. The company announced it submitted a compliance plan to Nasdaq.

Including Releases For "Nine Perfect Strangers" And "Truth Be Told," Strengthening Its Position In Physical Media With 23% Of FY 2024 Revenue From Exclusive Deals

AENT

Alliance Entertainment Partners With FIFTH SEASON For Exclusive Home Entertainment Distribution In US And Canada

Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $21.25, a high estimate of $23.00, and a low estimate of $19.00. Surpassing the previous average price target of $19.67, the current average has increased by 8.03%.
<img src="https://www.benzinga.com/files/images/story/2024/1732194074_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Gates Industrial Corp is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gates Industrial Corp. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Gates Industrial Corp compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Gates Industrial Corp's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/GTES/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Gates Industrial Corp analyst ratings.</a>
<h2>Unveiling the Story Behind Gates Industrial Corp</h2>
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment.
<h3>A Deep Dive into Gates Industrial Corp's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Gates Industrial Corp's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -4.83%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Gates Industrial Corp's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 5.73%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.51%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Gates Industrial Corp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.67%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 0.8, Gates Industrial Corp faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GTES

Evaluating Gates Industrial Corp: Insights From 4 Financial Analysts

Qualigen Therapeutics announces management changes

The latest announcement is out from Qualigen Therapeutics ( ($QLGN) ). Matt Korenberg resigned immediately as the chairman of the audit committee a...

Qualigen Therapeutics Board Experiences Key Changes

Univest Securities is acting as the sole placement agent for the offering. Published first on TheFly – the ultimate source for real-time, market-mo...

Qualigen Therapeutics files to sell 14M shares of common stock

Qualigen Therapeutics announces CEO and CFO retirements

Qualigen Therapeutics (QLGN) announced that it will implement a 1-for-50 reverse stock split of the issued shares of its common stock, effective at...

Qualigen Therapeutics to implement 1-for-50 reverse stock split

Qualigen Therapeutics ( ($QLGN) ) has issued an update. Qualigen Therapeutics is executing a 1-for-50 reverse stock split to boost its stock price ...

Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split

19:50 EST Qualigen Therapeutics (QLGN) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...

Qualigen Therapeutics trading halted, news pending

Qualigen Therapeutics ( ($QLGN) ) has issued an update. Graydon Bensler has been appointed as an independent board member, bringing over seven year...

Qualigen Therapeutics Appoints Graydon Bensler to Board

Qualigen Therapeutics (QLGN) has entered into definitive securities purchase agreements with several institutional and accredited investors for the...

Qualigen announces $4.5M private placement of Preferred Shares

Qualigen Therapeutics announces $4.5M private placement of convertible preferred shares

Press Releases

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

Management

Lifecore Biomedical Announces Cooperation Agreement with 22NW

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Qualigen Therapeutics, Inc. Announces management changes.

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

Comments

Qualigen Therapeutics

Qualigen Therapeutics (QLGN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga